
TG Therapeutics Inc. (NASDAQ: TGTX)’s 27.00-Percent Gain Of This Past Week Taught Us Something New
TG Therapeutics Inc. (NASDAQ:TGTX)’s traded shares stood at 6.95 million during the last session, with the company’s beta value hitting 1.99. At the close of